Health care stocks were mixed Friday afternoon, with the NYSE Health Care Index adding 0.1% and the State Street Health Care Select Sector SPDR ETF (XLV) fractionally lower.
The iShares Biotechnology ETF (IBB) increased 0.5%.
In corporate news, Merck (MRK) is in talks to buy Revolution Medicines (RVMD), the Financial Times reported Thursday. The deal, which could be announced in several weeks, is likely to be valued between $28 billion and $32 billion, the report said. Merck shares rose 0.7%, and Revolution gained 4.2%.
Amazon.com's (AMZN) pharmacy unit said Friday it now offers the pill version of Novo Nordisk's (NVO) Wegovy through insurance plans and cash-pay options. Novo shares gained 3%.
Liquidia (LQDA) shares surged nearly 16% after it reported preliminary Q4 net sales of Yutrepia of about $90.1 million, bringing full-year 2025 net sales to $148.3 million.
Comments